These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18199496)

  • 21. Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromes.
    Yan AT; Yan RT; Tan M; Fung A; Cohen EA; Fitchett DH; Langer A; Goodman SG;
    Arch Intern Med; 2007 May; 167(10):1009-16. PubMed ID: 17533203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute coronary syndromes in Europe: 1-year costs and outcomes.
    Taylor MJ; Scuffham PA; McCollam PL; Newby DE
    Curr Med Res Opin; 2007 Mar; 23(3):495-503. PubMed ID: 17355731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early invasive strategy improves outcomes in patients with acute coronary syndrome with previous coronary artery bypass graft surgery: a report from TACTICS-TIMI 18.
    Kugelmass AD; Sadanandan S; Lakkis N; Dibattiste PM; Robertson DH; Demopoulos LA; Gibson CM; Weintraub WS; Murphy SA; Cannon CP;
    Crit Pathw Cardiol; 2006 Sep; 5(3):167-72. PubMed ID: 18340233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial.
    Sculpher MJ; Lozano-Ortega G; Sambrook J; Palmer S; Ormanidhi O; Bakhai A; Flather M; Steg PG; Mehta SR; Weintraub W
    Am Heart J; 2009 May; 157(5):845-52. PubMed ID: 19376310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous coronary intervention versus coronary artery bypass grafting as primary revascularization in patients with acute coronary syndrome.
    Hochholzer W; Buettner HJ; Trenk D; Breidthardt T; Noveanu M; Laule K; Christ M; Schindler C; Neumann FJ; Mueller C
    Am J Cardiol; 2008 Jul; 102(2):173-9. PubMed ID: 18602516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.
    Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Itaya H; Shiba M; Wada M; Iijima R; Yamamoto M; Yamamoto M; Hara H; Takagi T; Asahara T; Mitsuo K; Kobayashi N; Sugi K
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):357-65. PubMed ID: 19638365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative troponin elevation does not provide incremental prognostic value beyond comprehensive risk stratification in patients with non-ST-segment elevation acute coronary syndromes.
    Lim KD; Yan AT; Casanova A; Yan RT; Mendelsohn A; Jolly S; Fitchett DH; Langer A; Goodman SG;
    Am Heart J; 2008 Apr; 155(4):718-24. PubMed ID: 18371482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early Invasive Versus Selective Strategy for Non-ST-Segment Elevation Acute Coronary Syndrome: The ICTUS Trial.
    Hoedemaker NPG; Damman P; Woudstra P; Hirsch A; Windhausen F; Tijssen JGP; de Winter RJ;
    J Am Coll Cardiol; 2017 Apr; 69(15):1883-1893. PubMed ID: 28408018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost effectiveness of enoxaparin in acute ST-segment elevation myocardial infarction: the ExTRACT-TIMI 25 (Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction 25) study.
    Marcoff L; Zhang Z; Zhang W; Ewen E; Jurkovitz C; Leguet P; Kolm P; Weintraub WS
    J Am Coll Cardiol; 2009 Sep; 54(14):1271-9. PubMed ID: 19778669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of transfer for patients with non-ST-segment elevation acute coronary syndrome from community to tertiary care hospitals.
    Roe MT; Chen AY; Delong ER; Boden WE; Calvin JE; Cairns CB; Smith SC; Pollack CV; Brindis RG; Califf RM; Gibler WB; Ohman EM; Peterson ED
    Am Heart J; 2008 Jul; 156(1):185-92. PubMed ID: 18585515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events.
    Sinnaeve PR; Steg PG; Fox KA; Van de Werf F; Montalescot G; Granger CB; Knobel E; Anderson FA; Dabbous OH; Avezum A;
    Arch Intern Med; 2009 Feb; 169(4):402-9. PubMed ID: 19237725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events.
    Devlin G; Gore JM; Elliott J; Wijesinghe N; Eagle KA; Avezum A; Huang W; Brieger D;
    Eur Heart J; 2008 May; 29(10):1275-82. PubMed ID: 18387940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of in-hospital revascularization on survival in patients with non-ST-elevation acute coronary syndrome and congestive heart failure.
    Steg PG; Kerner A; Van de Werf F; López-Sendón J; Gore JM; Fitzgerald G; Feldman LJ; Anderson FA; Avezum A;
    Circulation; 2008 Sep; 118(11):1163-71. PubMed ID: 18725494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost implication of an early invasive strategy on weekdays and weekends in patients with acute coronary syndromes.
    Lamy A; Tong WR; Bainey K; Gafni A; Rao-Melacini P; Mehta SR
    Can J Cardiol; 2015 Mar; 31(3):314-9. PubMed ID: 25746022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Greater benefit of early invasive strategy for unstable angina and non-ST elevation myocardial infarction in United States compared with non-United States patients: a TACTICS-TIMI 18 substudy.
    Herrmann HC; Murphy SA; Dibattiste PM; Delucca PT; Demopoulos LA; Gibson CM; Cannon CP
    Crit Pathw Cardiol; 2004 Jun; 3(2):95-100. PubMed ID: 18340148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of cardiac catheterization for non-ST-segment elevation acute coronary syndromes according to initial risk: reasons why physicians choose not to refer their patients.
    Lee CH; Tan M; Yan AT; Yan RT; Fitchett D; Grima EA; Langer A; Goodman SG;
    Arch Intern Med; 2008 Feb; 168(3):291-6. PubMed ID: 18268170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: results from the Treating to New Targets (TNT) Trial.
    Mark DB; Knight JD; Cowper PA; Davidson-Ray L; Anstrom KJ
    Am Heart J; 2008 Oct; 156(4):698-705. PubMed ID: 18926150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cost implications of an early versus delayed invasive strategy in Acute Coronary Syndromes: the TIMACS study.
    Bainey KR; Gafni A; Rao-Melacini P; Tong W; Steg PG; Faxon DP; Lamy A; Granger CB; Yusuf S; Mehta SR;
    J Med Econ; 2014 Jun; 17(6):415-22. PubMed ID: 24702256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term survival after surgery for acute coronary syndromes in relation to perioperative troponin T release and angina class - a prospective study in 200 patients.
    Bjessmo S; Svenarud P; Tran PK
    Thorac Cardiovasc Surg; 2009 Apr; 57(3):148-52. PubMed ID: 19330751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two different invasive versus noninvasive strategies in the management of non-ST elevation acute coronary syndromes.
    Sampaio F; Roberto J; Cruz F; Mateus P; Gonçalves C; Gonçalves M; Simões L; Gama V
    Rev Port Cardiol; 2007 Feb; 26(2):117-24. PubMed ID: 17479707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.